recent
develop
transmiss
vaccin
immun
rabbit
myxomatosi
rabbit
haemorrhag
diseas
base
recombin
myxoma
viru
mv
express
rabbit
haemorrhag
diseas
viru
rhdv
capsid
protein
rcena
et
al
horizont
transmiss
protect
myxomatosi
rabbit
haemorrag
diseas
use
recombin
myxoma
viru
j
virol
administr
recombin
viru
protect
rabbit
lethal
rhdv
mv
challeng
furthermor
recombin
viru
capabl
horizont
spread
promot
protect
contact
anim
thu
provid
opportun
immun
wild
rabbit
popul
howev
potenti
risk
must
extens
evalu
consid
use
studi
sever
safeti
issu
concern
propos
vaccin
evalu
laboratori
condit
result
indic
vaccin
administr
safe
even
overdos
undesir
eect
detect
upon
administr
immunosuppress
pregnant
rabbit
recombin
viru
maintain
attenu
phenotyp
passag
vivo
safeti
evalu
recombin
myxomarhdv
viru
induc
horizont
transmiss
protect
myxomatosi
rabbit
haemorrhag
diseas
myxomatosi
rabbit
haemorrhag
diseas
rhd
consid
major
viral
diseas
aect
european
rabbit
oryctolagu
cuniculu
myxoma
viru
mv
caus
agent
myxomatosi
belong
leporipoxviru
genu
poxvirida
famili
natur
host
sylvilagu
rabbit
america
mv
induc
mild
benign
infect
european
rabbit
howev
mv
caus
system
lethal
infect
known
myxomatosi
diseas
endem
entir
rabbit
rang
europ
sinc
deliber
releas
mv
franc
biolog
control
agent
wild
rabbit
popul
immun
domest
rabbit
myxomatosi
current
achiev
use
heterolog
vaccin
base
shope
viru
less
virul
leporipoxviru
homolog
vaccin
base
cell
cultureattenu
strain
mv
rhd
report
peopl
republ
china
diseas
spread
throughout
europ
endem
sinc
infect
rabbit
usual
die
within
h
necrotis
hepat
rhd
respons
high
econom
loss
rabbitri
well
high
mortal
rate
wild
rabbit
popul
etiolog
agent
rabbit
haemorrhag
diseas
viru
rhdv
member
calicivirida
famili
rhdv
virion
nonenvelop
icosahedr
capsid
compos
major
protein
compon
kda
commerci
vaccin
rhd
prepar
liver
experiment
infect
rabbit
sinc
vitro
system
avail
ecient
viru
propag
last
year
gene
success
express
sever
heterolog
system
shown
induc
full
protect
rabbit
lethal
challeng
rhdv
current
avail
vaccin
myxomatosi
rhd
proven
eectiv
control
diseas
domest
rabbit
suit
immun
wild
rabbit
popul
vaccin
need
deliv
individu
convent
veterinari
practic
feasibl
approach
vaccin
free
rang
anim
novel
approach
wildlif
vaccin
explor
possibl
develop
transmiss
vaccin
use
viral
vector
capabl
spread
within
anim
popul
order
protect
wild
rabbit
myxomatosi
rhd
construct
recombin
viru
base
natur
attenu
mv
strain
express
rhdv
protein
linear
epitop
tag
nucleoprotein
porcin
transmiss
gastroenter
coronaviru
tgev
includ
within
recombin
protein
allow
monitor
spread
recombin
viru
environ
follow
inocul
rabbit
recombin
viru
induc
antibodi
respons
mv
rhdv
well
tgev
tag
administr
subcutan
intraderm
oral
rout
protect
rabbit
lethal
rhdv
mv
challeng
furthermor
recombin
viru
show
limit
horizont
transmiss
capac
either
direct
contact
process
promot
immun
contact
uninocul
anim
promis
result
obtain
far
laboratori
condit
suggest
recombin
could
use
largescal
immun
scheme
control
myxomatosi
rhd
wild
rabbit
popul
howev
consid
environment
releas
vaccin
safeti
consider
extens
evalu
potenti
risk
regard
vaccin
dose
ie
accident
administr
overdos
age
physiolog
condit
ie
pregnant
immun
statu
expos
individu
taken
account
biolog
stabil
anoth
import
aspect
evalu
recombin
viru
intend
environment
releas
present
studi
report
safeti
evalu
laboratori
condit
recombin
viru
concern
mention
issu
recombin
viru
propag
rabbit
kidney
cell
line
grown
dulbecco
minimum
essenti
medium
dmem
supplement
foetal
bovin
serum
fb
mm
lglutamin
uml
penicillin
mgml
streptomycin
sirc
rabbit
cornea
cell
use
viral
titr
determin
plaqu
assay
rabbit
cell
line
obtain
american
type
cultur
collect
atcc
common
rabbit
brown
colour
free
antimv
antirhdv
antibodi
provid
commerci
breeder
rabbit
routin
use
restock
refer
wild
rabbit
group
eight
wild
rabbit
month
old
weigh
around
kg
free
mv
rhdv
antibodi
inocul
back
intraderm
id
subcutan
sc
rout
dierent
dose
vaccin
pfu
recombin
viru
rabbit
observ
daili
day
clinic
symptom
record
weight
temperatur
determin
made
anim
day
serum
sampl
extract
margin
ear
vein
rabbit
day
immun
use
evalu
serolog
respons
mv
rhdv
use
enzymelink
immunosorb
assay
elisa
previous
describ
antibodi
titr
reciproc
highest
dilut
give
valu
twofold
background
level
neg
control
rabbit
sera
group
eight
wild
rabbit
month
old
weigh
around
kg
immunosuppress
treatment
prednisolon
mg
per
anim
per
day
day
vaccin
day
vaccin
prednisolon
treat
rabbit
inocul
id
sc
rout
back
pfu
viru
control
rabbit
vaccin
treat
prednisolon
rabbit
observ
daili
period
day
clinic
symptom
record
weight
temperatur
determin
made
anim
day
serum
sampl
extract
day
immun
use
evalu
serolog
respons
mv
rhdv
elisa
antibodi
titr
describ
group
six
pregnant
inocul
dierent
time
gestat
day
sc
rout
back
pfu
viru
control
inocul
day
gestat
ml
phosphatebu
salin
pb
anim
observ
daili
gener
clinic
symptom
record
bodi
weight
temperatur
determin
perform
order
minimis
handlinginduc
stress
special
sensibl
gestat
follow
reproduct
paramet
record
second
parturit
number
anim
born
aliv
per
litter
number
anim
born
dead
per
litter
number
live
anim
per
litter
day
postparturit
dpp
weight
litter
dpp
two
rabbit
month
old
weigh
around
kg
inocul
id
rout
back
pfu
viru
seven
day
postvaccin
inocul
site
nodul
extract
homogen
pb
reinocul
two
new
rabbit
procedur
repeat
passag
viru
obtain
last
passag
titrat
eect
inocul
pfu
sc
group
eight
rabbit
evalu
describ
compar
origin
recombin
viru
serum
sampl
extract
day
immun
use
evalu
serolog
respons
mv
rhdv
elisa
antibodi
titr
describ
order
evalu
genet
stabil
viru
passag
rabbit
dna
extract
nodul
inocul
site
analys
pcr
oligonucleotid
use
deriv
mv
genom
foreign
gene
insert
site
pcr
product
instead
product
obtain
wildtyp
mv
indic
presenc
insert
gene
construct
data
analys
use
student
ttest
nonpair
variant
consid
previou
work
show
pfu
ecient
vaccin
dose
ensur
horizont
transmiss
protect
myxomatosi
rhd
either
direct
contact
process
evalu
eect
administ
overdos
vaccin
wild
rabbit
inocul
id
sc
rout
dierent
dose
viru
pfu
order
obtain
semiquantit
measur
allow
graphic
represent
object
comparison
classic
myxomatosi
symptom
rank
point
see
tabl
result
regist
observ
period
repres
fig
rabbit
inocul
id
rout
display
similar
clinic
sign
vaccin
dose
test
consist
localis
primari
nodul
inocul
site
rabbit
scanti
secondari
skin
lesion
form
small
discret
nodul
usual
less
cm
diamet
face
ear
eyelid
lesion
appear
day
postinocul
dpi
complet
resolv
rabbit
normal
dpi
none
infect
rabbit
exhibit
classic
sever
myxomatosi
symptom
like
closur
eye
generalis
oedema
respiratori
syndrom
fig
rabbit
inocul
sc
rout
show
similar
clinic
symptom
consist
group
eight
wild
rabbit
inocul
id
rout
q
r
pfu
rabbit
observ
daili
period
day
clinic
sign
due
viru
infect
anim
rank
accord
tabl
milder
less
secondari
nodul
slightli
smaller
resolv
earlier
result
shown
febril
respons
loss
bodi
weight
detect
tabl
show
temperatur
increas
regist
dpi
dpi
well
weight
increas
day
day
dierenc
increas
bodi
temperatur
bodi
weight
observ
recombin
virusinfect
rabbit
compar
control
rabbit
regardless
viru
dose
inocul
rout
evalu
immun
respons
elicit
inocul
rabbit
sera
sampl
obtain
dpi
monitor
elisa
presenc
antimv
antirhdv
antibodi
inocul
rabbit
develop
high
antimv
antirhdv
antibodi
titr
increas
vaccin
dose
tabl
gross
dierenc
antibodi
titr
induc
vaccin
administr
id
sc
inocul
rout
evalu
eect
recombin
viru
infect
immunocompromis
anim
rabbit
immunosuppress
treatment
prednisolon
treat
rabbit
inocul
sc
id
rout
pfu
viru
clinic
sign
due
viru
infect
compar
induc
control
rabbit
vaccin
treat
prednisolon
fig
tabl
result
indic
administr
viru
immunocompromis
anim
safe
either
id
sc
rout
prednisolon
treat
rabbit
exhibit
mild
clinic
symptom
complet
recov
dpi
fig
show
graphic
represent
symptomatolog
observ
rabbit
inocul
id
rout
accord
rank
myxomatosi
clinic
sign
establish
tabl
id
inocul
immunosuppress
rabbit
exhibit
similar
local
lesion
observ
control
nonimmunosuppress
rabbit
lesion
appear
time
dpi
case
show
subtl
tendenc
resolv
later
immunosuppress
rabbit
dpi
vs
dpi
result
obtain
rabbit
inocul
sc
rout
essenti
data
shown
dierenc
bodi
temperatur
increas
bodi
weight
increas
observ
immunosuppress
rabbit
compar
control
rabbit
tabl
humor
immun
respons
elicit
dpi
prednisolon
treat
control
rabbit
similar
vaccin
rabbit
develop
high
antimv
antirhdv
antibodi
titr
tabl
secondari
skin
lesion
form
small
discret
nodul
near
inocul
site
face
ear
small
discret
nodul
eyelid
small
nodul
genit
limb
part
bodi
sever
myxomatosi
symptom
like
closur
eye
generalis
oedema
respiratori
syndrom
death
evalu
eect
recombin
viru
infect
reproduct
pregnant
inocul
dierent
time
gestat
day
sc
rout
daili
observ
anim
show
total
absenc
gener
clinic
symptom
inocul
anim
reproduct
paramet
number
anim
born
aliv
per
litter
number
anim
born
dead
per
litter
number
live
anim
per
litter
dpp
averag
weight
litter
dpp
second
parturit
summaris
tabl
overal
result
show
recombin
viru
infect
induc
alter
reproduct
pregnant
infect
dierent
day
gestat
show
reproduct
valu
expect
rang
rabbit
dierenc
observ
recombin
virusinfect
compar
control
inocul
pb
day
gestat
absenc
alter
reproduct
paramet
maintain
follow
parturit
tabl
furthermor
none
rabbit
born
virusinfect
show
symptomatolog
associ
myxomatosi
biolog
stabil
recombin
viru
therefor
potenti
evolv
virul
state
evalu
compar
eect
rabbit
infect
passag
viru
viru
stock
use
experi
report
paper
eect
rabbit
infect
viru
obtain
serial
passag
rabbit
passag
viru
fig
show
graphic
represent
symptomatolog
observ
rabbit
infect
either
passag
passag
viru
accord
rank
myxomatosi
clinic
sign
establish
tabl
rabbit
infect
passag
viru
exhibit
mild
clinic
sign
infect
passag
viru
symptom
appear
dpi
complet
resolv
dpi
case
none
infect
rabbit
exhibit
classic
sever
myxomatosi
symptom
tabl
show
temperatur
increas
dpi
dpi
well
weight
fig
eect
administ
viru
immunosuppress
rabbit
group
eight
rabbit
treat
r
untreat
q
prednisolon
inocul
id
rout
pfu
viru
rabbit
observ
daili
period
day
clinic
sign
due
viru
infect
anim
rank
accord
tabl
increas
day
dierenc
bodi
temperatur
increas
bodi
weight
increas
observ
rabbit
infect
passag
viru
compar
rabbit
infect
passag
viru
control
uninfect
rabbit
humor
respons
elicit
rabbit
infect
passag
passag
viru
similar
infect
rabbit
develop
high
antimv
antirhdv
antibodi
titr
genom
stabil
viru
analys
pcr
use
oligonucleotid
primer
extern
insert
site
gene
serial
passag
rabbit
product
kb
expect
size
recombin
viru
pcr
detect
correspond
wildtyp
mv
kb
product
shown
indic
gene
stabli
integr
mv
genom
number
vaccin
avail
protect
rabbit
myxomatosi
rhd
use
immun
domest
rabbit
howev
control
diseas
among
wild
rabbit
popul
remain
unsolv
problem
great
concern
regard
note
european
rabbit
play
key
ecolog
role
mediterranean
ecosystem
addit
rabbit
among
import
small
game
speci
sever
european
countri
immun
wildlif
dicult
achiev
direct
deliveri
vaccin
free
rang
anim
possibl
oral
rout
consid
feasibl
way
vaccin
administr
exampl
oral
vaccin
use
control
enzoot
sylvat
rabi
europ
north
america
mean
recombin
vacciniarabi
vaccin
deliv
bait
altern
strategi
use
ransmiss
vaccin
ie
viral
vector
capabl
spread
within
anim
popul
hope
administr
recombin
vaccin
characterist
small
number
captur
individu
would
eventu
lead
immun
fraction
anim
within
given
popul
sucient
reduc
spread
target
diseas
approach
might
use
especi
distribut
size
turnov
rate
popul
preclud
captur
bait
techniqu
mean
antigen
deliveri
european
rabbit
exampl
popul
mind
develop
transmiss
vaccin
myxomatosi
rhd
base
recombin
viru
capabl
spread
rabbit
popul
result
obtain
laboratori
condit
suggest
recombin
viru
might
eectiv
wild
rabbit
immun
howev
sinc
propos
use
involv
environment
releas
recombin
viru
consider
regard
safeti
issu
import
potenti
ecaci
candid
vaccin
reason
safeti
concern
core
ration
design
propos
immun
strategi
biolog
characterist
mv
make
good
candid
vaccin
vector
term
safeti
consider
mv
exhibit
restrict
host
rang
infect
exclus
rabbit
sylvilagu
oryctolagu
spp
viru
wide
distribut
throughout
europ
australia
america
nearli
year
evid
infect
speci
thu
host
restrict
natur
mv
minimis
risk
recombin
vaccin
spread
nontarget
speci
natur
hand
given
current
widespread
geograph
distribut
mv
similar
distribut
rhdv
use
recombin
vaccin
would
normal
involv
introduct
viru
speci
alreadi
exist
particular
area
safeti
aspect
also
consid
choic
parent
mv
strain
decid
use
one
avail
vaccin
strain
obtain
cell
cultureattenu
virul
mv
strain
would
involv
releas
new
strain
environ
might
undergo
revers
virul
natur
instead
decid
use
attenu
mv
strain
alreadi
circul
among
wild
rabbit
popul
strain
select
survey
mv
strain
circul
spain
analys
virul
transmiss
strain
exhibit
adequ
biolog
characterist
develop
recombin
transmiss
vaccin
caus
nonpathogen
infect
compar
cell
cultureattenu
vaccin
strain
yet
retain
capac
horizont
spread
sinc
preserv
valuabl
biolog
properti
strain
major
import
develop
recombin
viru
foreign
gene
insert
intergen
site
orf
recombin
mv
insert
site
shown
retain
overal
parent
biolog
characterist
moreov
express
cassett
insert
mv
genom
use
td
twostep
select
system
procedur
enabl
construct
recombin
poxvirus
without
marker
gene
insert
recombin
viral
genom
thu
recombin
harbour
select
marker
antibiot
resist
gene
widespread
current
regard
major
health
environment
threat
consid
potenti
risk
associ
dna
sequenc
insert
note
gene
clone
wide
rang
heterolog
system
indic
toxic
side
eect
associ
express
report
previou
result
indic
administr
either
mv
recombin
viru
healthi
rabbit
laboratori
condit
standardis
procedur
safe
rabbit
exhibit
mild
clinic
symptom
rapidli
recov
report
extend
safeti
assess
vaccin
analys
potenti
tabl
eect
concern
vaccin
dosag
possibl
accident
administr
overdos
result
demonstr
vaccin
safeti
even
overdos
pfu
inocul
fig
tabl
assess
vaccin
eect
immunosuppress
rabbit
consid
relev
given
incid
natur
immunocompromis
individu
due
infect
environment
genet
caus
reason
assay
eect
vaccin
administr
rabbit
treat
prednisolon
potent
immunosuppressor
treatment
induc
deplet
circul
eosinophil
mononuclear
cell
caus
strong
decreas
tcell
respons
slight
eect
bcell
function
commonli
use
procedur
safeti
evalu
veterinari
vaccin
result
show
prednisolon
treat
rabbit
exhibit
similar
symptom
observ
control
rabbit
fig
tabl
remark
observ
immunosuppress
rabbit
show
subtl
tendenc
delay
resolut
local
lesion
dpi
vs
dpi
fig
anoth
import
aspect
address
eect
viru
infect
reproduct
result
show
recombin
viru
inocul
alter
reproduct
paramet
none
rabbit
born
vaccin
show
myxomatosisassoci
clinic
sign
tabl
conclus
overal
result
obtain
demonstr
notabl
lack
advers
eect
attribut
recombin
viru
regardless
dose
rout
life
histori
stage
individu
ie
neonat
young
pregnant
immunocompromis
final
biolog
stabil
recombin
viru
analys
environment
releas
recombin
viru
would
involv
certain
number
serial
passag
natur
host
even
capabl
seem
limit
two
serial
passag
laboratori
condit
tendenc
viru
evolv
virul
state
serial
passag
rabbit
would
caus
accordingli
biolog
stabil
studi
subject
viru
serial
passag
rabbit
result
obtain
fig
tabl
indic
recombin
viru
maintain
grossli
biolog
characterist
passag
thu
attenu
natur
seem
stabl
trait
hand
genet
analysi
indic
gene
remain
stabli
integr
mv
genom
serial
passag
rabbit
agreement
previous
report
result
obtain
serial
passag
viru
cell
monolay
basi
result
previous
report
present
paper
along
experiment
data
address
safeti
ecaci
issu
publish
elsewher
recombin
subject
mandatori
risk
assess
process
rel
releas
organ
limit
trial
authoris
spanish
compet
author
cours
trial
assess
ecaci
safeti
vaccin
control
condit
perspect
use
largescal
program
control
myxomatosi
rhd
among
wild
rabbit
popul
